BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium

  October 27, 2026

   · 

  8 min read
• Press Releases

  Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

  October 27, 2026

   · 

  9 min read
• Press Releases

  Immuron continued quarterly sales growth - October 27, 2026

  October 27, 2026

   · 

  10 min read
• Press Releases

  Carnyx Therapeutics Advances Lead Oral Sleep Candidate CNYX-005 into IND-Enabling Development

  October 27, 2026

   · 

  4 min read
• Press Releases

  Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

  October 27, 2026

   · 

  3 min read
• Press Releases

  Merakris Advances Potentially Pivotal MTX-001 Phase 2/3 Strategy Following FDA Pre-IND Meeting

  October 27, 2026

   · 

  5 min read
• Press Releases

  Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants

  October 27, 2026

   · 

  4 min read
• Press Releases

  Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026

  October 27, 2026

   · 

  2 min read
• Press Releases

  Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome

  October 27, 2026

   · 

  9 min read
• Press Releases

  Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma

  October 27, 2026

   · 

  14 min read